Phenylpiracetam, is a Phenylpiracetam product with nootropic* effects. Experimental studies have proved it to be effective in improving memory and learning capacity.
This medicine has a sedative effect, which does not influence the activity of the autonomous nervous system. Its action is mildly disinhibitory and antidepressant.Phenylpiracetam is a nootropic drug derived from piracetam, and is more potent (i.e. lower dosage is used). It belongs to the racetam family of nootropics. Phenylpiraceta was developed by Parke-Davis based on Piracetam, and is 8-30 times stronger than Piracetam.
1. Improves mood.
2. Helps fight fatigue.
3. Prevents oxidation within the brain.
4. Treats alcohol related brain damage.
5. Prevents caffeine withdrawal symptoms.
Phenylpiracetam (INN: fonturacetam, brand names Phenotropil Фенотропил, Carphedon), is a phenylated analog of the drug piracetam. It was developed in 1983 as a medication for Soviet Cosmonauts to treat the prolonged stresses of working in space. Phenylpiracetam was created at the Russian Academy of Sciences Institute of Biomedical Problems in an effort led by psychopharmacologist Valentina Ivanovna Akhapkina. In Russia it is now available as a prescription drug. Research on animals has indicated that phenylpiracetam may have anti-amnesic, antidepressant, anticonvulsant, anxiolytic, and memory enhancement effects. A few small clinical studies have shown possible links between prescription of phenylpiracetam and improvement in a number of encephalopathic conditions, including lesions of cerebral blood pathways, traumatic brain injury and certain types of glioma. Phenylpiracetam reverses the depressant effects of the benzodiazepine diazepam, increases operant behavior, inhibits post-rotational nystagmus, prevents retrograde amnesia, and has anticonvulsant properties.